Broker gives 4 reasons why Commonwealth Bank of Australia has further to fall

Commonwealth Bank of Australia (ASX:CBA) is bouncing back today after yesterday's fall. But there are reasons to think the gains won't last.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Big bank stocks are staging a comeback this morning following yesterday's beating on news of a Royal Commission into the financial industry with Commonwealth Bank of Australia (ASX: CBA) leading the decline with a 2% drop in its share price to $79.43.

But this morning's reprieve could be short-lived, particularly for our largest home lender, as there are reasons outside of the Royal Commission that leave Commonwealth Bank susceptible to further falls.

It's an issue of strength turning into weakness. Morgan Stanley has identified four reasons why Commonwealth Bank has historically traded at a premium over its peers National Australia Bank Ltd. (ASX: NAB), Australia and New Zealand Banking Group (ASX: ANZ) and Westpac Banking Corp (ASX: WBC).

The tailwinds have now shifted and the broker is warning that Commonwealth Bank has further to de-rate.

De-rating refers to the increase in the risk assessment for the stock. The higher the perceived risks, the bigger the valuation discount (leading to a lower valuation of the stock).

The four key strengths that are now waning are 1) Strategy, execution and franchise strength; 2) Stronger growth and excess capital generation; 3) Stronger balance sheet and lower risk profile; and 4) Tight share register.

The first point speaks to how well Commonwealth Bank's management has delivered on its strategic plan vs. its peers over the past decade. But this is changing because of the impending change in the CEO, which may well be an external appointment. This adds uncertainty for investors in the near term.

The bank also has the strongest retail banking franchise, according to Morgan Stanley. But this is likely to be somewhat wilted away due to recent concerns about the bank's misconduct (AUSTRAC case) and the scrutiny the Royal Commission will put on the bank's behaviour.

On the second point, Morgan Stanley believes Commonwealth Bank's P/E premium to its peers was justified by stronger earnings per share (EPS) and revenue growth over the past 5 to 10 years.

However, the bank's ability to sustain this is under a cloud with the broker noting the end of the mortgage bull market and growing regulatory and community pressure. This in turn will impact on the bank's dividend flexibility and scope to lift returns though capital management.

The third point is on the Commonwealth Bank's balance sheet. The broker believes the funding advantage the bank had over its peers from having a greater share of domestic savings accounts is less than what it was a decade ago.

Further, analysis done by the broker showed that Commonwealth Bank is not any less vulnerable to an increase in bad debts than Westpac or National Australia Bank, even though the market views Commonwealth Bank as having the lowest credit risk.

Lastly, Commonwealth Bank has the largest proportion of retail shareholders (and still does) compared to the other big banks. Unlike institutional investors, retail shareholders are less likely to sell the stock when it looks expensive.

"However, we believe this source of support for trading multiples is not as strong as it was because the proportion of retail shareholders has fallen and the difference vs. peers has narrowed from ~14% to ~8% over the past decade," concluded the broker.

Morgan Stanley has an "underweight" recommendation on the stock with a price target of $71 a share.

There are better blue-chip opportunities in our market. The experts at the Motley Fool have uncovered three that are worth putting on your radar for 2018. Click on the link below to get your hands on the free report.

Motley Fool contributor Brendon Lau owns shares of Australia & New Zealand Banking Group Limited, National Australia Bank Limited, and Westpac Banking. The Motley Fool Australia owns shares of National Australia Bank Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »